Replies to post #3936 on Else Nutrition Holdings Inc (BABYF)

[janeyH]

ask yourself: what justified the 250?

[pual]

Personally I think $2.50 (market cap of $250m) represented expected value based on ongoing buildup of both producuc line and marketing/selling infrastucture.

In any case, I assume market will wait for financials of Q3 AND Q4 to figure out the value of this investment. Uplisting will also bring in key institutional investors who by policy do stay away from OTC stocks.

[Yaafah]

The floodgates will open once the baby formula is approved by the FDA..that has always been the story...

Current studies etc will only reinforce what is already known about the products Else is currently manufacturing and selling.

I see a fully functional, well funded, expertly run company with a huge future and a kickass marketing department.

That justifies the 2.50 price or more...currently.

Else is a breath of fresh air...my expectations have me buying more at these levels and even as it moves up.

This hasn't even begun to blossom the way it will in the next year or so.


I started buying at .38 cents CDN a long time ago...and purchased more shares most recently @ 2.54..

Happy to do so....like buying undervalued GOLD.

The uplisting is coming too as per Hamutal Yitzhak at the recent conference where she delivered a presentation on behalf of the company a few weeks ago.

Can't wait...